455 related articles for article (PubMed ID: 10947056)
1. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(30):685-7. PubMed ID: 10947056
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
3. From the Centers for Disease Control and Prevention. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
JAMA; 2000 Oct; 284(13):1641-2. PubMed ID: 11041738
[No Abstract] [Full Text] [Related]
4. Association between HIV and tuberculosis: technical guide.
Bull Pan Am Health Organ; 1993; 27(3):297-310. PubMed ID: 8220525
[TBL] [Abstract][Full Text] [Related]
5. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
[TBL] [Abstract][Full Text] [Related]
6. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
[TBL] [Abstract][Full Text] [Related]
8. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
[TBL] [Abstract][Full Text] [Related]
9. Results of testing for human immunodeficiency virus infection among recent contacts of infectious tuberculosis cases in the United States.
Reichler MR; Bur S; Reves R; Mangura B; Thompson V; Ford J; Castro KG
Int J Tuberc Lung Dis; 2003 Dec; 7(12 Suppl 3):S471-8. PubMed ID: 14677840
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
Gordin FM; Matts JP; Miller C; Brown LS; Hafner R; John SL; Klein M; Vaughn A; Besch CL; Perez G; Szabo S; El-Sadr W
N Engl J Med; 1997 Jul; 337(5):315-20. PubMed ID: 9233868
[TBL] [Abstract][Full Text] [Related]
11. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
13. Presumptive TB prophylaxis rejected.
Torres G
GMHC Treat Issues; 1997 Oct; 11(10):5-6. PubMed ID: 11364822
[TBL] [Abstract][Full Text] [Related]
14. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
Cohn DL
Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
[TBL] [Abstract][Full Text] [Related]
15. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
Apers L; Lynen L; Worodria W; Colebunders R
Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid TB prophylaxis effective in drug users with HIV.
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
[TBL] [Abstract][Full Text] [Related]
17. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States.
Lee LM; Lobato MN; Buskin SE; Morse A; Costa OS
Int J Tuberc Lung Dis; 2006 Feb; 10(2):209-14. PubMed ID: 16499263
[TBL] [Abstract][Full Text] [Related]
18. Preventing tuberculosis among HIV-infected persons: a survey of physicians' knowledge and practices.
DeRiemer K; Daley CL; Reingold AL
Prev Med; 1999 Apr; 28(4):437-44. PubMed ID: 10090874
[TBL] [Abstract][Full Text] [Related]
19. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
Fitzgerald DW; Morse MM; Pape JW; Johnson WD
Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
[TBL] [Abstract][Full Text] [Related]
20. Positive PPD and chemoprophylaxis for tuberculosis infection.
Pickwell SM
Am Fam Physician; 1995 Jun; 51(8):1929-34, 1937-8. PubMed ID: 7762484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
